Literature DB >> 22222938

Migraine responsive to warfarin: an update on anticoagulant possible role in migraine prophylaxis.

F Maggioni1, M Bruno, F Mainardi, C Lisotto, G Zanchin.   

Abstract

We report the case of a patient suffering from migraine with and without aura who had a complete remission of both during warfarin treatment for pulmonary embolism; the attacks reappeared promptly during two treatment withdrawals. We highlight warfarin as prophylactic drug in migraine prophylaxis and discuss about new, safer and more specific anticoagulants that could be used in migraine treatment. Their use could also clarify literature's conflicting data about anticoagulants' efficacy in migraine prophylaxis and clear if their efficacy in migraine treatment could be related aspecifically to anticoagulation's effect or to a particular mechanism in the coagulation cascade.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22222938     DOI： 10.1007/s10072-011-0926-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


  15 in total

1.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

Review 2.  New oral anticoagulant drugs in cardiovascular disease.

Authors:  Ingo Ahrens; Gregory Y H Lip; Karlheinz Peter
Journal:  Thromb Haemost       Date:  2010-06-10       Impact factor: 5.249

Review 3.  The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism.

Authors:  Thomas Mavrakanas; Henri Bounameaux
Journal:  Pharmacol Ther       Date:  2010-12-24       Impact factor: 12.310

4.  Reduction of migraine attacks during the use of warfarin.

Authors:  Y D Fragoso
Journal:  Headache       Date:  1997 Nov-Dec       Impact factor: 5.887

5.  Patients with acenocoumarol treatment and migraine.

Authors:  F Morales-Asín; C Iñiguez; R Cornudella; J A Mauri; F Espada; E E Mostacero
Journal:  Headache       Date:  2000-01       Impact factor: 5.887

6.  Effect of low-intensity acenocoumarol on frequency and severity of migraine attacks.

Authors:  Elisabeth A Wammes-van der Heijden; Martijn H Smidt; Cees C Tijssen; Annelies R van't Hoff; Albert W Lenderink; Antoine C G Egberts
Journal:  Headache       Date:  2005-02       Impact factor: 5.887

7.  Reduction of migrainous headaches during the use of acenocoumarol.

Authors:  E P van Puijenbroek; A C Egberts; J F Trooster; J Zomerdijk
Journal:  Headache       Date:  1996-01       Impact factor: 5.887

8.  A thromboembolic predisposition and the effect of anticoagulants on migraine.

Authors:  Elisabeth A Wammes-van der Heijden; Cees C Tijssen; Annelies R van't Hoff; Antoine C G Egberts
Journal:  Headache       Date:  2004-05       Impact factor: 5.887

Review 9.  Stroke and migraine.

Authors:  Jesse Weinberger
Journal:  Curr Cardiol Rep       Date:  2007-03       Impact factor: 2.931

10.  Warfarin treatment and migraine.

Authors:  C G Suresh; D Neal; M O Coupe
Journal:  Postgrad Med J       Date:  1994-01       Impact factor: 2.401
View more
  4 in total

1.  Patent Foramen Ovale With Atrial Septal Aneurysm Is Strongly Associated With Migraine With Aura: A Large Observational Study.

Authors:  Roel J R Snijder; Justin G L M Luermans; Albert H de Heij; Vincent Thijs; Wouter J Schonewille; Alexander Van De Bruaene; Martin J Swaans; Werner I H L Budts; Martijn C Post
Journal:  J Am Heart Assoc       Date:  2016-12-01       Impact factor: 5.501

2.  A replication study separates polymorphisms behind migraine with and without depression.

Authors:  Peter Petschner; Daniel Baksa; Gabor Hullam; Dora Torok; Andras Millinghoffer; J F William Deakin; Gyorgy Bagdy; Gabriella Juhasz
Journal:  PLoS One       Date:  2021-12-31       Impact factor: 3.240

3.  An unusual case report on the possible role of Warfarin in migraine prophylaxis.

Authors:  Angelo Russo; Sara Santi; Daniela Gueraldi; Maria De Paola; Fabiana Zani; Luigi Alberto Pini
Journal:  Springerplus       Date:  2013-02-12

Review 4.  Migraine and risk of stroke.

Authors:  Lise R Øie; Tobias Kurth; Sasha Gulati; David W Dodick
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-03-26       Impact factor: 10.154
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.